1. W. Habib, R. Khankari, J. Hontz. Fast-dissolving drug
delivery systems, Critical review in therapeutics,
Drug Carrier Systems, 17(1): 61-72 (2000).
2. H. Seager. Drug delivery products and Zydis fast
dissolving dosage form, J. Pharm. Phamacol. 50:
375-382 (1998).
Manoj et al., ARPB, 2014; Vol 4 (IV) ISSN 2250-0774
(REVIEW ARTICLE)
783 | P a g e w w w . a r p b . i n f o
3. B. S. Kuchekar, C. Badhan, H. S. Mahajan. Mouth
dissolving tablets: A novel drug delivery system,
Pharma Times 35: 7-9 (2003).
4. L. V. Allen and B. Wang. Particulate support matrix
for making a rapidly dissolving tablet, 1997, US
Patent 5595761.
5. W. S. Pebley, N. E. Jager, S. J. Thompson. Rapidly
disintegrating tablets, US Patent No. 5, 298, 261,
1994.
6. A. C. Liang and L. H. Chen. Fast-dissolving intraoral
drug delivery systems, Expert Opin. Ther. Patents,
2001, 11(6).
7. Y. Morita, Y. Tsusima, M. Yasui, R. Termoz, J. Ajioka
and E. Takayama. Evaluation of disintegration time
of rapidly disintegrating tablets via a Novel Method
Utilizing a CCD Camera, Chem. Pharm. Bull., 50(9):
1181-1186 (2002).
8. S. Schiermeir and P. C. Schmidt. Fast dispersible
ibuprofen tablets, Eur. J. Pharm Sci. 15, 2002, 295-
305,
9. M. Siewert, J. Dressman, C. Brown and V. Shah.
FIP/AAPS Guidelines for Dissolution/In Vitro
Release Testing of Novel/Special Dosage Forms,
Dissolution Technologies, February 2003.
10. Y. Fu, S. Yang, S. H. Jeong, S. Kimura, K. Park. Orally
fast disintegrating tablets: development,
technologies, taste-masking and clinical studies,
Crit. Rev. Ther. Drug Carr. Syst., 21 (6): 433–475
(2004).
11. R. H. Bogner, M. F. Wilkosz. Fast-dissolving tablets:
new dosage convenience for patients, U. S. Pharm.
27: 34–43 (2002).
12. L. H. Reddy, B. Ghose and Rajneesh. Indian J. Pharm.
Sci., 64(4): 331- 336 (2002).
13. B. S. Kuchekar and V. Arumugam. Indian J. Pharm.
Edu., 35: 150 (2001).
14. S. Bhaskaran, and G. V. Narmada. Indian Pharmacist
1(2): 9-12 (2002).
15. A. Kumar et al. A review on evaluation and
formulation of fast dissolving tablets, International
Journal of Drug Research and Technology 1(1): 8-
16 (2011).
16. A. Modi et al. Formulation and evaluation of fast
dissolving tablets of diclofenac sodium using
different superdisintegrants by direct compression
method, Pharmacia 1(3): 95-101 (2012).
17. R. Bradoo. Fast Dissolving Drug Delivery Systems,
JAMA India. 4(10): 27-31 (2001).
18. R. K. Chang, X. Guo, B. A. Burnside, R. Couch. Fast
dissolving tablets, Pharma Tech 24(6): 52-58
(2000).
19. S. Kumari, S. Visht, P. K. Sharma, R. K. Yadav. Fast
dissolving Drug delivery system: Review, Journal of
Pharmacy Research 3(6): 1444-1449 (2010).
20. D. V. Kumar, I. Sharma, V. Sharma. A Comprehensive
review on fast dissolving tablet technology, Journal
of Applied Pharmaceutical Science 01(05): 50-58
(2011).
21. S. Shaikh, R. V. Khirsagar, A. Quazi. Fast
disintegrating tablets: an overview of formulations
and technologies, International Journal of Pharmacy
and Pharmaceutical Sciences 2(3): 9-11 (2010).
22. T. Makino, M. Yamada, J. Kikuta. Fast dissolving
tablet and its production, European Patent, 1993,
0553777 A2.
23. R. Shangraw, Mitrevej, M. Shah. A New Era of Tablet
Disintegrants, Pharm. Tech., 4 (10): 48–57 (1980).
24. V. N. Deshmukh. Mouth Dissolving Drug Delivery
System: A Review, International Journal of Pharm
Tech Research 4(1): 412-421 (2012).
25. A. R. Gosai, S. B. Patil, K. K. Sawant. Formulation and
Evaluation of Orodispersible Tablets of
Ondansetron Hydrochloride by Direct Compression
using Superdisintegrants, International Journal of
Pharmaceutical Sciences and Nanotechnology, 1(1):
1-6 (2008).
26. R. Kumar, M. B. Patil, S. R. Patil, M. S. Paschapur, R.
Mahalaxmi. Development and Characterization of
Orodispersible Tablets of aceclofenac by
sublimation technique. In. J. Pharma tech res. 1(2):
1-6 (2009).
27. D. Bhandari. Recent Trends - Fast dissolving tablet,
Pharmainfo.net. 6(6): 12-16 (2008).
28. B. G. Prajapati, N. Ratnakar. A Review on recent
patents on Fast Dissolving Drug Delivery System,
Int. J. Pharm Tech Res. 1(3): 790-798 (2009).
29. I. S. Ahmed, M. M. Nafadi, F. A. Fatahalla.
Formulation of fast-dissolving ketoprofen tablet
using freeze- drying in blisters technique, Drug Ind.
Pharm. 32(4): 437-42 (2006).
30. H. Takagi, A. Kajiyama, M. Yanagisawa. Rapidly
disintegrable pharmaceutical composition, 2005,
U.S. Patent, 6, 899, 899.
31. M. Cirri, M. Valleri, P. Mura, F. Maestrelli, R.
Ballerini. Development of fast-dissolving tablets
flurbiprofen-cyclodextrin complexes, Drug Dev. Ind.
Pharm. 31(7): 697-707 (2005).
32. M. Ohta, E. Hayakawa, K. Ito, S. Tokuno, K.
Morimoto, V. Watanabe. Intrabuccally rapidly
disintegrating tablet, 1997, WO Patent 9, 747, 287.
33. Indian Pharmacopoeia, Vol-2, The Controller of
Publication Delhi, 1996, pp. 735.
Manoj et al., ARPB, 2014; Vol 4 (IV) ISSN 2250-0774
(REVIEW ARTICLE)
784 | P a g e w w w . a r p b . i n f o
34. L. Lachman, H. Liberman, J. Kanig. The theory and
practice of industrial pharmacy, 3rd edn., Varghese
Publishing House, Mumbai, 1987, 297.
35. S. Khan, P. Kataria, P. Nakhat, P. Yeole. Taste
masking of ondansetron hydrochloride by polymer
carrier system and formulation of
rapid-disintegrating tablets, AAPS Pharm. Sci. Tech.
8(2): 46 (2007).
36. Y. X. Bi, H. Sunada, Y. Yonezawa, K. Danjo.
Evaluation of rapidly disintegrating tablets
prepared by a direct compression method, Drug
Dev Ind Pharm. 25: 571-581 (1999). doi:
10.1081/DDC-100102211.
37. Y. Morita, Y. Tsushima, M. Yasui, R. Termoz, J. Ajioka,
K. Takayama. Evaluation of the disintegration time
of rapidly disintegrating tablets via a novel method
utilizing a CCD camera. Chem. Pharm. Bull., 50(9):
1181-1186 (2002).
38. United States Pharmacopoeia USP25 NF20, The
Official Compendia of Standards, First annual Asian
edn., Rockville, MD: United States Pharmacopoeial
Convention Inc. 2002.
39. C. G. Wilson, N. Washington, Peach, G. R. Murray, J.
Kennerley. The behaviour of a Fast dissolving
dosage form (Expidet) followed by gammascintigraphy,
Int J Pharm 40 (1–2): 119–123
(1987).
40. C. G. Wilson, N. Washington, S. Norman, J. L.
Greaves, J. M. Peach, K. A. Pugh. Gamma
scintigraphic study to compare oesophageal
clearance of "Expidet" formulations, tablets and
capsules in supine volunteers, Int J Pharm 46(3):
241–246 (1988)
Thank you for copying data from http://www.arastirmax.com